261945-75-9 Usage
Uses
Used in Organic Synthesis:
1-bromo-2,5-difluoro-4-(trifluoromethyl)benzene is used as a building block in organic synthesis for the preparation of various chemicals. Its unique structure allows for versatile reactions and the creation of a wide range of compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, 1-bromo-2,5-difluoro-4-(trifluoromethyl)benzene is utilized as a key intermediate in the development of drug molecules. Its presence in the molecular structure can influence the pharmacological properties and therapeutic effects of the resulting compounds.
Used in Chemical Industry:
1-bromo-2,5-difluoro-4-(trifluoromethyl)benzene is also used in the chemical industry for the production of specialty chemicals and materials that require specific functional groups and properties.
Safety and Environmental Considerations:
Due to its halogenated nature, 1-bromo-2,5-difluoro-4-(trifluoromethyl)benzene requires careful handling and disposal to ensure safety and environmental protection. Special procedures may be necessary to manage its use and disposal in various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 261945-75-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,9,4 and 5 respectively; the second part has 2 digits, 7 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 261945-75:
(8*2)+(7*6)+(6*1)+(5*9)+(4*4)+(3*5)+(2*7)+(1*5)=159
159 % 10 = 9
So 261945-75-9 is a valid CAS Registry Number.
261945-75-9Relevant academic research and scientific papers
5,6,7,8-TETRAHYDRO-IMIDAZO[1,5-A]PYRAZINE DERIVATIVES
-
Page/Page column 42, (2008/12/06)
The invention relates to 5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine derivatives of formula (I),wherein X represents CH2 or O; R1 represents a phenyl group, which group is independently mono-, di-, or tri-substituted wherein the substituents are independently selected from the group consisting of (C1-4)alkyl, (C1-4)alkoxy, halogen, cyano, trifluoromethoxy and trifluoromethyl; R2 represents (C1-4)alkyl, (C1-4)alkoxy, (C2-4)alkenyl, halogen, cyano, hydroxymethyl, trifluoromethyl, C(O)NR5R6 or cyclopropyl; R3 represents (C1-4)alkyl, (C1-4)alkoxy-methyl or halogen; R4 represents (C1-4)alkyl; R5 represents hydrogen or (C1-4)alkyl; and R6 represents hydrogen or (C1-4)alkyl. The invention also relates to pharmaceutically acceptable salts of such compounds; and to the use of such compounds as medicaments; especially as orexin receptor antagonists.
